Subject
Physiology (medical),Biochemistry
Reference61 articles.
1. Neuregulin 4 suppresses NASH-HCC development by restraining tumor-prone liver microenvironment;Zhang;Cell Metabol.,2022
2. Lenvatinib combined with transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma: a phase III, randomized clinical trial (LAUNCH);Peng;J. Clin. Oncol.,2022
3. Cancer statistics, 2022;Siegel;CA A Cancer J. Clin.,2022
4. Lenvatinib with or without concurrent drug-eluting beads transarterial chemoembolization in patients with unresectable, advanced hepatocellular carcinoma: a real-world, multicenter, retrospective study;Xia;Liver Cancer,2022
5. Cisplatin in liver cancer therapy;Hamaya;Int. J. Mol. Sci.,2023
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献